SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Aug. 2, 2006--Hana Biosciences (NASDAQ:HNAB), a biopharmaceutical company focused on advancing cancer care, announced today that Mark Ahn, PhD, President & Chief Executive Officer, will present a company update at the Canaccord Adams Summer Seminar on Tuesday, August 8th at 3:30pm EDT in the NY Main Room at The Marriott Long Wharf Hotel in Boston, MA.
